Bristol-Myers Squibb | BMY - 流动资产





流动资产 更改 日
AbbVie USD 33.67B 140M 2026-06
Abbott USD 25.51B 488M 2026-03
ALKERMES USD 1.52B 164.26M 2026-06
Amgen USD 34.96B 3.49B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Biogen USD 7.31B 1.88B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Coherus Biosciences USD 133.79M 72.25M 2026-06
Drreddys Laboratories INR 301.98B 298.66B 2026-03
Eli Lilly USD 64.67B 9.84B 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
J&J USD 59.77B 601M 2026-06
Medtronic USD 24.07B 75M 2025-12
Merck USD 36.68B 1.66B 2026-06
Novartis USD 27.35B 744M 2026-06
Novo Nordisk DKK 208.7B 31.38B 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Phibro Animal Health USD 894.07M 31.88M 2026-03
Prestige Brands USD 496.81M 65.33M 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Sanofi EUR 30.16B 789M 2026-03
United Therapeutics USD 3.48B 611.7M 2026-06
Zoetis USD 6.36B 118M 2026-06